Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

PRC2 loss induces chemoresistance by repressing apoptosis in T cell acute lymphoblastic leukemia.

Ariës IM, Bodaar K, Karim SA, Chonghaile TN, Hinze L, Burns MA, Pfirrmann M, Degar J, Landrigan JT, Balbach S, Peirs S, Menten B, Isenhart R, Stevenson KE, Neuberg DS, Devidas M, Loh ML, Hunger SP, Teachey DT, Rabin KR, Winter SS, Dunsmore KP, Wood BL, Silverman LB, Sallan SE, Van Vlierberghe P, Orkin SH, Knoechel B, Letai AG, Gutierrez A.

J Exp Med. 2018 Nov 7. pii: jem.20180570. doi: 10.1084/jem.20180570. [Epub ahead of print]

PMID:
30404791
2.

An Achilles' Heel for MLL-Rearranged Leukemias: Writers and Readers of H3 Lysine 36 Dimethylation.

Balbach ST, Orkin SH.

Cancer Discov. 2016 Jul;6(7):700-2. doi: 10.1158/2159-8290.CD-16-0564.

3.

News on Clinical Details and Treatment in PGM1-CDG.

Schrapers E, Tegtmeyer LC, Simic-Schleicher G, Debus V, Reunert J, Balbach S, Klingel K, Du Chesne I, Seelhöfer A, Fobker M, Marquardt T, Rust S.

JIMD Rep. 2016;26:77-84. doi: 10.1007/8904_2015_471. Epub 2015 Aug 25.

4.

Proposal of a genetic classifier for risk group stratification in pediatric T-cell lymphoblastic lymphoma reveals differences from adult T-cell lymphoblastic leukemia.

Balbach ST, Makarova O, Bonn BR, Zimmermann M, Rohde M, Oschlies I, Klapper W, Rössig C, Burkhardt B.

Leukemia. 2016 Apr;30(4):970-3. doi: 10.1038/leu.2015.203. Epub 2015 Jul 28. No abstract available.

PMID:
26216196
5.

Live embryo imaging to follow cell cycle and chromosomes stability after nuclear transfer.

Balbach ST, Boiani M.

Methods Mol Biol. 2015;1222:149-59. doi: 10.1007/978-1-4939-1594-1_11.

PMID:
25287344
6.

Characterization and evaluation of a modified PVPA barrier in comparison to Caco-2 cell monolayers for combined dissolution and permeation testing.

Gantzsch SP, Kann B, Ofer-Glaessgen M, Loos P, Berchtold H, Balbach S, Eichinger T, Lehr CM, Schaefer UF, Windbergs M.

J Control Release. 2014 Feb 10;175:79-86. doi: 10.1016/j.jconrel.2013.12.009. Epub 2013 Dec 19.

PMID:
24361370
7.

Compound selection for development - is salt formation the ultimate answer? Experiences with an extended concept of the "100mg approach".

Korn C, Balbach S.

Eur J Pharm Sci. 2014 Jun 16;57:257-63. doi: 10.1016/j.ejps.2013.08.040. Epub 2013 Sep 11.

PMID:
24036162
8.

Reprogramming of two somatic nuclei in the same ooplasm leads to pluripotent embryonic stem cells.

Pfeiffer MJ, Esteves TC, Balbach ST, Araúzo-Bravo MJ, Stehling M, Jauch A, Houghton FD, Schwarzer C, Boiani M.

Stem Cells. 2013 Nov;31(11):2343-53. doi: 10.1002/stem.1497.

9.

Mitochondrial physiology and gene expression analyses reveal metabolic and translational dysregulation in oocyte-induced somatic nuclear reprogramming.

Esteves TC, Psathaki OE, Pfeiffer MJ, Balbach ST, Zeuschner D, Shitara H, Yonekawa H, Siatkowski M, Fuellen G, Boiani M.

PLoS One. 2012;7(6):e36850. doi: 10.1371/journal.pone.0036850. Epub 2012 Jun 5.

10.

Nuclear reprogramming: kinetics of cell cycle and metabolic progression as determinants of success.

Balbach ST, Esteves TC, Houghton FD, Siatkowski M, Pfeiffer MJ, Tsurumi C, Kanzler B, Fuellen G, Boiani M.

PLoS One. 2012;7(4):e35322. doi: 10.1371/journal.pone.0035322. Epub 2012 Apr 18.

11.

Proteomic analysis of mouse oocytes reveals 28 candidate factors of the "reprogrammome".

Pfeiffer MJ, Siatkowski M, Paudel Y, Balbach ST, Baeumer N, Crosetto N, Drexler HC, Fuellen G, Boiani M.

J Proteome Res. 2011 May 6;10(5):2140-53. doi: 10.1021/pr100706k. Epub 2011 Mar 29.

PMID:
21344949
12.

Enhancing somatic nuclear reprogramming by Oct4 gain-of-function in cloned mouse embryos.

Pfeiffer MJ, Balbach ST, Esteves TC, Crosetto N, Boiani M.

Int J Dev Biol. 2010;54(11-12):1649-57. doi: 10.1387/ijdb.103197mp.

13.

Somatic cell nuclear reprogramming of mouse oocytes endures beyond reproductive decline.

Esteves TC, Balbach ST, Pfeiffer MJ, Araúzo-Bravo MJ, Klein DC, Sinn M, Boiani M.

Aging Cell. 2011 Feb;10(1):80-95. doi: 10.1111/j.1474-9726.2010.00644.x. Epub 2010 Dec 7.

14.

Governing cell lineage formation in cloned mouse embryos.

Balbach ST, Esteves TC, Brink T, Gentile L, McLaughlin KJ, Adjaye JA, Boiani M.

Dev Biol. 2010 Jul 1;343(1-2):71-83. doi: 10.1016/j.ydbio.2010.04.012. Epub 2010 Apr 22.

15.

Online monitoring of transepithelial electrical resistance (TEER) in an apparatus for combined dissolution and permeation testing.

Muendoerfer M, Schaefer UF, Koenig P, Walk JS, Loos P, Balbach S, Eichinger T, Lehr CM.

Int J Pharm. 2010 Jun 15;392(1-2):134-40. doi: 10.1016/j.ijpharm.2010.03.046. Epub 2010 Mar 25.

PMID:
20347022
16.

Subsets of cloned mouse embryos and their non-random relationship to development and nuclear reprogramming.

Cavaleri FM, Balbach ST, Gentile L, Jauch A, Böhm-Steuer B, Han YM, Schöler HR, Boiani M.

Mech Dev. 2008 Jan-Feb;125(1-2):153-66. Epub 2007 Sep 29.

17.

Chromosome stability differs in cloned mouse embryos and derivative ES cells.

Balbach ST, Jauch A, Böhm-Steuer B, Cavaleri FM, Han YM, Boiani M.

Dev Biol. 2007 Aug 15;308(2):309-21. Epub 2007 Jun 2.

18.

Production of cloned mice by somatic cell nuclear transfer.

Kishigami S, Wakayama S, Thuan NV, Ohta H, Mizutani E, Hikichi T, Bui HT, Balbach S, Ogura A, Boiani M, Wakayama T.

Nat Protoc. 2006;1(1):125-38.

PMID:
17406224
19.

Automated measurement of permeation and dissolution of propranolol HCl tablets using sequential injection analysis.

Motz SA, Klimundová J, Schaefer UF, Balbach S, Eichinger T, Solich P, Lehr CM.

Anal Chim Acta. 2007 Jan 2;581(1):174-80. Epub 2006 Aug 5.

PMID:
17386442
20.

Permeability assessment for solid oral drug formulations based on Caco-2 monolayer in combination with a flow through dissolution cell.

Motz SA, Schaefer UF, Balbach S, Eichinger T, Lehr CM.

Eur J Pharm Biopharm. 2007 May;66(2):286-95. Epub 2006 Oct 28.

PMID:
17156983
21.

Population pharmacokinetics of methylprednisolone in accident victims with spinal cord injury.

Barth J, Winkler J, Schumann R, Nagaraja NV, Madabushi R, Balbach S, Derendorf H, Möllmann H, Möllenhoff G.

Int J Clin Pharmacol Ther. 2004 Sep;42(9):504-11.

PMID:
15487809
22.

Pharmaceutical evaluation of early development candidates "the 100 mg-approach".

Balbach S, Korn C.

Int J Pharm. 2004 May 4;275(1-2):1-12. Review.

PMID:
15081133
23.

Concentrations of insulin-like growth factor (IGF)-I, -II, and IGF binding protein-4, and -5 in human bone cell conditioned medium do not change with age.

Pfeilschifter J, Diel I, Klöppinger T, Bismar H, Schuster EM, Balbach S, Ziegler R, Baylink D, Mohan S.

Mech Ageing Dev. 2000 Aug 15;117(1-3):109-14.

PMID:
10958927
24.
25.

[2-Guanidino-4(3H)-quinazolinones with chemotherapeutic activities].

Kreutzberger A, Balbach S.

Pharmazie. 1993 Jan;48(1):17-20. German.

PMID:
8384724

Supplemental Content

Loading ...
Support Center